Navigation Links
Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014
Date:7/22/2014

Los Angeles, CA (PRWEB) July 22, 2014

Holomic is expanding its portfolio of rapid test solutions with the debut of its fluorescent immunoassay reader, the HRDR-300, at the American Association of Clinical Chemistry (AACC) meeting in Chicago, July 28-31, 2014. Available in both portable Smartphone based or bench top versions, the HRDR-300 is a highly sensitive, low-cost fluorescent reader that uses patent pending technology to analyze fluorescent lateral flow immunoassays with high sensitivity and accuracy.

The HRDR-300 provides a comprehensive rapid test solution to manufacturers and end-users of fluorescent tests. For manufacturers, the HRDR-300 fluorescent reader can be used as a universal reader for tests of all formats and sizes and at prices that compete with similar bench top instruments in the market. Coupled with Holomic’s ‘Test Developer', rapid test vendors can obtain deeper insight into the performance of their tests and create reader calibration files for download by end users.

Other features include test and lot number identification as well as test and patient data retrieval from bar/QR codes. The reader has lab and field applications with connectivity to a secure CLOUD server for remote data access and analytics as well as EHR and LIS integration.

The HRDR-300 is a key addition to Holomics portfolio of rapid test solutions that already comprises of chromatographic readers and software and data management solutions. With a suite of reader products, the company has developed customized reader solutions for the clinic/home-use, global health and lateral flow immunoassay manufacturing markets. The HRDR-300 is compliant with ISO13485 and is registered with the FDA as a Class 1 medical device. Visit http://www.holomic.com for more information.

Holomic will showcase the HRDR-300 and other rapid test solutions at the AACC meeting in Chicago at booth #2043, July 29-31, 2014. Holomic will also exhibit the same at Medica in Dusseldorf, November 12-15, 2014. Contact Ketaki Sood, Director of Product Marketing, ketaki(at)holomic(dot)com, 310.443.2070, http://www.holomic.com.

The HRDR-300 is available for sale globally. In the US, it is available for Research Use Only. Not for use in diagnostic procedures.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12027542.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
2. Tianli-Xiduhei(TM) Black Pork Meat Makes Official Debut in Beijing Food Stores
3. Leica Microsystems Debuts First 3D Surgical Microscopes with TrueVision® Technology Inside, at AANS Annual Meeting in New Orleans
4. PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP
5. SoundConnect Debuts on Inc. 5000 List of Fastest Growing Companies
6. Neurophotonics to debut at SPIE Photonics Europe 2014
7. Bayer CropScience Debuts Serenade Optimum to Help Growers Control Tough Diseases and Combat Resistance
8. JCB Laboratories Debuts High Tech Monitoring System That Will Further Enhance Patient Safety, Surpass Compounding Pharmacy Standards
9. ATCC Announces Agreement with Life Technologies Corporation to Sell and Distribute Green Fluorescent Protein (GFP)-based Materials
10. Goodbye, fluorescent light bulbs! See your office in a new light
11. Research on China's FISH Probe (Fluorescent in Situ Hybridization Probe) Industry, 2013-2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):